Earendil Labs, Sanofi Ink Global License Deal for Next-Gen Autoimmune Therapies

Earendil Labs, Sanofi Ink Global License Deal for Next-Gen Autoimmune Therapies

Earendil Labs and Sanofi today announced that they have entered into a license agreement for two potential first-in-class bispecific antibodies in the field of autoimmune and inflammatory bowel diseases.
Health Ministry, Sanofi strengthen cooperation in pharmaceutical industry development

Health Ministry, Sanofi strengthen cooperation in pharmaceutical industry development

Sanofi-Aventis Vietnam Co., Ltd. is seeking to strengthen cooperation with the Ministry of Health (MoH) to increase access to new medicines for Vietnamese people and promote the local pharmaceutical industry development.
Sanofi hosts series of seminars on influenza

Sanofi hosts series of seminars on influenza

Sanofi Southeast Asia and India organised a series of scientific seminars on influenza on November 11-13 in Ho Chi Minh City.
Sanofi steps up efforts to boost community health in Vietnam

Sanofi steps up efforts to boost community health in Vietnam

Sanofi is continuing to step up its efforts to boost community health in Vietnam.
Sanofi strives to ensure environmental compliance

Sanofi strives to ensure environmental compliance

Sanofi is seeking to reduce its environmental impact.
Sanofi says to reach settlement on Zantac lawsuits in US

Sanofi says to reach settlement on Zantac lawsuits in US

French pharmaceutical giant Sanofi said Thursday it had reached a preliminary agreement on settling thousands of US lawsuits concerning its heartburn drug Zantac.
Connecting rare traits into pathways for rare disease patients

Connecting rare traits into pathways for rare disease patients

Diagnosing, treating and caring for patients with rare diseases is a big challenge no matter where they are in the world, so various stakeholders have teamed up to support them.
Self-care unlocks potential of fast-moving consumer healthcare in Vietnam

Self-care unlocks potential of fast-moving consumer healthcare in Vietnam

The wave of self-care in Vietnam allows foreign pharmaceutical companies to focus on fast-moving consumer healthcare to complement the current system.
French groups keen to back green schemes

French groups keen to back green schemes

Sustainable green development and expanding investment links between France and Vietnam are being highlighted as the two countries celebrate the 50th anniversary of diplomatic relations and 10 years of strategic partnership this year.
Pharma giants gaining big in 2022

Pharma giants gaining big in 2022

International pharma giants have reported strong results for the first half of 2022, with new plans in the pipeline from many of them in this country.
Sanofi's leader sees Vietnam as a promising market for healthcare

Sanofi's leader sees Vietnam as a promising market for healthcare

Vietnam is emerging as a promising market for healthcare in the region, according to Marc-Antoine Lucchini, head of Foundation and General Medicines at Sanofi.
Sanofi-Aventis Vietnam joins efforts to reduce plastic waste

Sanofi-Aventis Vietnam joins efforts to reduce plastic waste

Sanofi-Aventis Vietnam on June 17 entered a cooperation agreement with FPT Long Chau to implement the Insulin Pen Sustainability Pilot Project.
Multinationals get health PPP fever

Multinationals get health PPP fever

Although legal issues remain in some areas, public-private collaboration continues to be a focus among multinational corporations in Vietnam’s healthcare sector, and further expansions are being sought.
Sanofi unveils new corporate brand and logo

Sanofi unveils new corporate brand and logo

Sanofi unveiled a new bold and unifying corporate brand that supports the modernisation and transformation the company launched in December 2019.
Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine

Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine

Sanofi and GSK on February 23 announced that they intend to submit data from both their booster and phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccines.
1 2 3

Latest News